Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Irach Taraporewala Insider Profile
4 Followers
Irach Taraporewala, Chief Executive Officer, Director at NeuBase Therapeutics, holds 45.60K shares in NeuBase Therapeutics (Ticker: NBSE). Most recently, Irach Taraporewala Bought $3,705 shares of NeuBase Therapeutics on Feb 10, 2015 for an estimated value of 25.01K.
Irach Taraporewala has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Irach Taraporewala's holdings
Insider Roles
Chief Executive Officer, Director
Roles that Irach Taraporewala holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Irach Taraporewala
Irach Taraporewala's Trading History
List of latest transactions for each holding click on a transaction to see Irach Taraporewala's performance on stock
You May Also Like
Irach Taraporewala insider profile FAQ
What is the percentage of profitable transactions made by Irach Taraporewala?
The percentage of profitable transactions made by Irach Taraporewala is ―.
What is the average return per transaction made by Irach Taraporewala?
The average return per transaction made by Irach Taraporewala is ―.
What stocks does Irach Taraporewala hold?
Irach Taraporewala holds: NBSE stocks.
What was Irach Taraporewala’s latest transaction?
Irach Taraporewala latest transaction was an Informative Buy of $25.01K.
What was Irach Taraporewala's most profitable transaction?
Irach Taraporewala’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Irach Taraporewala's role in NeuBase Therapeutics?
Irach Taraporewala's role in NeuBase Therapeutics is Chief Executive Officer, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.